Key Details
Price
$12.76Annual ROE
-67.67%Beta
1.12Events Calendar
Next earnings date:
Mar 26, 2025Recent quarterly earnings:
Nov 07, 2024Recent annual earnings:
Mar 26, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
09 Aug '24 Morgan Stanley
Overweight18 June '24 Stifel
Buy07 June '24 Raymond James
Outperform11 Aug '23 Morgan Stanley
Equal-Weight16 Dec '22 Morgan Stanley
Equal-Weight16 Dec '22 Jefferies
Hold10 Oct '22 Morgan Stanley
Overweight10 Oct '22 Jefferies
Buy10 Oct '22 Cowen & Co.
OutperformMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Third Harmonic Bio doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Wall Street Analysts Believe Third Harmonic Bio, Inc. (THRD) Could Rally 26.67%: Here's is How to Trade
THRD
zacks.com11 November 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in Third Harmonic Bio, Inc. (THRD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference
THRD
GlobeNewsWire31 August 2023
SAN FRANCISCO, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced that Chief Executive Officer Natalie Holles will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Tuesday, September 12, 2023, from 7:30-7:55 a.m. ET.
FAQ
- What is the primary business of Third Harmonic Bio?
- What is the ticker symbol for Third Harmonic Bio?
- Does Third Harmonic Bio pay dividends?
- What sector is Third Harmonic Bio in?
- What industry is Third Harmonic Bio in?
- What country is Third Harmonic Bio based in?
- When did Third Harmonic Bio go public?
- Is Third Harmonic Bio in the S&P 500?
- Is Third Harmonic Bio in the NASDAQ 100?
- Is Third Harmonic Bio in the Dow Jones?
- When was Third Harmonic Bio's last earnings report?
- When does Third Harmonic Bio report earnings?
- Should I buy Third Harmonic Bio stock now?
What is the primary business of Third Harmonic Bio?
Third Harmonic Bio (THRD) is a biotechnology company focused on developing innovative therapies for autoimmune and inflammatory diseases. They aim to harness the power of the immune system to create effective treatments, improving patients' quality of life through advanced research and drug development.
What is the ticker symbol for Third Harmonic Bio?
The ticker symbol for Third Harmonic Bio is NASDAQ:THRD
Does Third Harmonic Bio pay dividends?
No, Third Harmonic Bio does not pay dividends
What sector is Third Harmonic Bio in?
Third Harmonic Bio is in the Healthcare sector
What industry is Third Harmonic Bio in?
Third Harmonic Bio is in the Biotechnology industry
What country is Third Harmonic Bio based in?
Third Harmonic Bio is headquartered in United States
When did Third Harmonic Bio go public?
Third Harmonic Bio's initial public offering (IPO) was on 14 September 2022
Is Third Harmonic Bio in the S&P 500?
No, Third Harmonic Bio is not included in the S&P 500 index
Is Third Harmonic Bio in the NASDAQ 100?
No, Third Harmonic Bio is not included in the NASDAQ 100 index
Is Third Harmonic Bio in the Dow Jones?
No, Third Harmonic Bio is not included in the Dow Jones index
When was Third Harmonic Bio's last earnings report?
Third Harmonic Bio's most recent earnings report was on 7 November 2024
When does Third Harmonic Bio report earnings?
The next expected earnings date for Third Harmonic Bio is 26 March 2025
Should I buy Third Harmonic Bio stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions